BioCentury
ARTICLE | Clinical News

Paxil paroxetine: Marketed to treat depression, social anxiety disorder

April 2, 2001 7:00 AM UTC

In a U.S. post-marketing trial of Paxil in 40 patients with malignant melanoma receiving high-dose interferon-alpha therapy, the incidence of depression was reduced in patients receiving paroxetine co...